GoodRx Holdings (GDRX) Return on Capital Employed (2020 - 2026)

GoodRx Holdings has disclosed Return on Capital Employed across 7 years of filings, most recently posting 9.15% for Q1 2026.

• Return on Capital Employed for Q1 2026 came in at 9.15%, up 254.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 9.15% (up 254.0% YoY), and the FY2025 annual result was 7.61%, up 278.0% from the prior year.
• Return on Capital Employed came in at 9.15% for Q1 2026 at GoodRx Holdings, up from 7.82% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 9.15% in Q1 2026 to a low of 2.2% in Q1 2024.
• The 5-year median for Return on Capital Employed is 2.26% (2024), against an average of 2.69%.
• Across the five-year window, Return on Capital Employed jumped 2702 bps in 2022 and slumped 315 bps in 2024, its largest moves.
• GoodRx Holdings' Return on Capital Employed stood at 0.12% in 2022, then slumped by 1637 bps to 1.77% in 2023, then soared by 398 bps to 5.28% in 2024, then surged by 48 bps to 7.82% in 2025, then climbed by 17 bps to 9.15% in 2026.
• The last three Return on Capital Employed figures came in at 9.15% (Q1 2026), 7.82% (Q4 2025), and 7.28% (Q3 2025), per Business Quant data.